BioXcel Therapeutics (BTAI) Other Operating Expenses (2022 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Other Operating Expenses of $283000.0 for Q1 2026, up 1921.43% year-over-year from $14000.0 in Q1 2025, and up 784.38% quarter-over-quarter from $32000.0 in Q4 2025.
BioXcel Therapeutics (BTAI) Other Operating Expenses (2022 - 2026) Analysis & Trends
BioXcel Therapeutics' Other Operating Expenses history runs 5 years deep, the most recent figure standing at $283000.0 for Q1 2026.
- In Q1 2026, Other Operating Expenses rose 1921.43% year-over-year to $283000.0; the TTM figure through Mar 2026 stood at $433000.0 (down 79.15% YoY), while the FY2025 annual figure was $164000.0, down 92.35% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $283000.0, up from $32000.0 in the prior quarter.
- The five-year high for Other Operating Expenses was $1.2 million in Q3 2024, with the low at $9000.0 in Q4 2022.
- The 5-year median for Other Operating Expenses is $62000.0 (2024), against an average of $258066.7.
- The sharpest annual moves came in 2023 and 2025: Other Operating Expenses soared 7833.33% in 2023, then tumbled 99.06% in 2025.
- BioXcel Therapeutics' Other Operating Expenses stood at $9000.0 in 2022, then jumped by 7833.33% to $714000.0 in 2023, then advanced by 16.39% to $831000.0 in 2024, then sank by 96.15% to $32000.0 in 2025, then soared by 784.38% to $283000.0 in 2026.
- Business Quant data shows BTAI's Other Operating Expenses at $283000.0 in Q1 2026, $32000.0 in Q4 2025, and $11000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | BioXcel Therapeutics | 24.25 Mn | 24.25 Mn | 160,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22,000.00 |
| Mar 31, 2026 | 283,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 107,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 831,000.00 |
| Sep 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 62,000.00 |
| Mar 31, 2024 | 80,000.00 |
| Dec 31, 2023 | 714,000.00 |
| Sep 30, 2023 | 512,000.00 |
| Jun 30, 2023 | 26,000.00 |
| Mar 31, 2023 | 9,000.00 |
| Dec 31, 2022 | 9,000.00 |
| Sep 30, 2022 | 11,000.00 |